We report the synthesis, anti-inflammatory and antioxidant activities of novel quinoxaline and quinoxaline 1,4-di-N-oxide derivatives. Microwave assisted methods have been used in order to optimize reaction times and to improve the yields. The tested compounds presented important scavenging activities and promising in vitro inhibition of soybean lipoxygenase. Two of the best lipoxygenase inhibitors (compounds 7b and 8f) were evaluated as in vivo antiinflammatory agents using the carrageenin-induced edema model. One of them (compound 7b) showed important in vivo anti-inflammatory effect (41%) similar to that of indomethacin (47%) used as the reference drug.
Introduction
Arachidonic acid (AA) metabolism, mediated by the LOX enzyme family, leads to the generation of leukotrienes, a type of pro-inflammatory mediators, that are involved in processes such as fever, asthma 1 or cardiovascular disease. 2 Aberrant AA metabolism is also related to carcinogenesis. In that respect, recent studies revealed increased LOX expression levels in a wide range of cancers including pancreatic, bladder or breast cancer. [3] [4] [5] On the other hand, during the inflammation process, phagocytic leukocytes (e.g. neutrophils, monocytes, macrophages, eosinophils) produce reactive oxygen species (ROS), such as superoxide radical anion, hydrogen peroxide and hydroxyl radical. The presence of high levels of ROS induce and heighten certain pathological conditions such as carcinogenesis, atherosclerosis and neurodegenerative diseases [6] [7] [8] and are well known to be involved in the induction and prolongation of inflammatory process. 9, 10 The involvement of ROS in inflammation is confirmed by a number of commercially available non-steroidal anti-inflammatory drugs NSAIDs (acetaminophen, salicylates, indomethacin and nimesulide) that have been demonstrated to possess radical scavenging properties. [11] [12] [13] [14] Taking into account the above mentioned relationship between ROS and inflammation as well as the importance of inhibition of LOX to combat inflammatory and carcinogenic processes, the development of new compounds having both anti-inflammatory and antioxidant activities and being LOX inhibitors constitutes an interesting approach in the obtention of new drugs for cancer prevention, treatment of chronic inflammation and other related pathological conditions. Quinoxaline 1,4-di-N-oxide derivatives are a class of compounds having a great interest in medicinal chemistry as they display a broad range of biological properties such as antibacterial, anticancer or antiparasitic. [15] [16] [17] We have demonstrate 18 that quinoxaline 1,4-di-N-oxide derivatives show also very interesting antioxidant and antiinflammatory properties, some of them displaying an in vivo anti-inflammatory effect higher than the reference drug, indomethacin IMA, and promising in vitro inhibition values of LOX (<1μM). Based on these results and with the aim of obtaining new compounds with improved activities we now describe the synthesis, antioxidant and in vivo anti-inflammatory activity and LOX inhibition of a wide number of new quinoxaline and quinoxaline 1,4-di-N-oxide derivatives. Several structural modifications have been carried out ( Figure 1 ) in order to determine the structural requirements of this kind of compounds to act as anti-inflammatory and antioxidant agents. The classic Claisen-Schmidt condensation, used to synthesize compounds with α,β-unsaturated ketone system (such as compounds in series 1), did not react in the same expected way to obtain compounds in series 4 and 5. Thus, a Wittig reaction was proposed to obtain the desired compounds (Scheme 1). Usually, these reactions, that consist in a condensation between an aldehyde and an ylide to afford the corresponding α,β-unsaturated ketone system derivative, are carried out in a dichloromethane reflux during 5 or 6 hours. 20 After a deep study of the reaction conditions we optimized a microwave assisted method for the synthesis of these two series concluding that the use of the microwave improved conversion ratios and decreased reaction times. As shown in Scheme 1, both aldehyde and ylide had to be previously synthesized. Aldehydes IV were obtained by two different methods: one of them included deprotection of an acetal group in acid medium; the other involved a methyl oxidation using SeO 2 as the oxidant agent. 21 The second method was found to be the most appropriate for the synthesis of these aldehydes as a huge volume of solvent was needed in the first one to do the extraction. In addition, a microwave assisted method was developed by our group to carry out this reaction. The starting compounds II and III were synthesized by the classic Beirut reaction 22 between the appropriate BFX and the corresponding carbonilic derivative using pyrrolidine or morpholine as the catalyst. Obtention of ylide VI required a reaction between triphenylphosphine and the corresponding alkyl halide V and a subsequent treatment with a weak base. 20 In the case of series 5, the halide was commercially available and the formation of the ylide was carried out by using a microwave assisted method. The synthesis of ylide in series 4 was performed by a conventional route as the microwave did not work as expected with this reaction. The required halide was previously synthesized as reported 20 and used without purification to obtain the ylide, that could be the reason of the failure of the microwave assisted synthesis. Synthesis of series 6 was carried out by a Claisen-Schmidt condensation between the corresponding 6,7-substituted 2-acetyl-3-methyl quinoxaline VIII and 3,4,5-Trimethoxy-benzaldehyde using 3% sodium hydroxide in methanol (Scheme 2). Starting compounds VIII were obtained by reduction of the N-oxide groups 23 of compounds VII 24 with Na 2 S 2 O 4 . While the reaction to obtain series 1 was performed at low temperature 18 it was possible to carry out the condensation at room temperature to obtain compounds of series 6 and this fact resulted in much better yields. Cyclization of the α,β-unsaturated ketone system in compounds of series 6 yield compounds of series 7, 8 and 9 (Scheme 2). Formation of a six-membered ring (series 7) was carried out in an isopropanol reflux in the presence of guanidine and KOH as the catalyst. Reaction between compounds of series 6 and hydrazine gave compounds of series 8 and in the same way, compounds of series 2 reacted with hydrazine to afford compounds of series 10. The conventional method to synthesize 3,5-substituted 1-(4-sulfamylphenyl) pyrazolines (compounds 9) consists of an eight-hour ethanol reflux. 25 We optimized a microwave assisted method for the preparation of this series 9 and we managed to reduce the volume of solvent, the reaction times and, as a consequence, possible secondary reactions.
Antioxidant activity
The estimation of the antioxidant potential of the synthesized compounds was assessed by several different assays in order to study a wider spectrum of scavenging properties. The results obtained were compared to well known Table 1 . Interaction percentage with DPPH (DPPH %) at 0.05 mM, 0.1 mM and 0.2 mM; Antioxidant determination using the ABTS cation radical-percentage inhibition (ABTS %) moiety (compounds 3c, 3e, 3f, 8c, 8f and 10a) and among them, those with N-oxide groups in the quinoxaline ring (3c, 3e, 3f and 10a) exhibited significantly increased activity compared to their reduced analogues (8c and 8f). Thus, the presence of the N-oxide groups in these compounds might increase the acidity of the amino group making easier the release of the hydrogen atom and so increasing their scavenging activity. The presence of both NH and OH groups in the same molecule (compound 10a) seemed to strengthen its antioxidant character.
For compounds 2e, 2f, 3c, 3e, 3f the interaction values were found to be time and concentration dependent. 26 The pre-formed radical monocation of 2,2'-azinobis-(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS ·+ ) is generated by oxidation of ABTS with potassium persulfate and reduced in the presence of hydrogen-donating antioxidants. The decolorization of the blue/green solution (due to the ABTS ·+ color) after the treatment with the compound is indicative of its scavenging ability. In the same way as DPPH interaction, the best activities in the ABTS assay (table 1) were shown by compounds of series 2, 3, 8 and 10 (2e, 2f, 3c, 3e, 3f, 8c, 8f and 10a) with a phenolic group and/or a free amino pyrazoline ring in the structure. Nevertheless, these activities seemed to have the opposite trend of that showed in the DPPH assay, as the best derivatives were those with a phenol group (compounds 2e and 2f) followed by compounds of series 8 (8c and 8f) and series 3 (3c, 3e and 3f). Surprisingly, compounds of series 6 (6a-f)showed quite good values of ABTS ·+ scavenging ability as well as compound 7b that displayed an activity similar to that of compounds of series 3.
Superoxide radical anion (·O 2 -) and hydroxyl radical (·OH) scavenging activity. The ability of the compounds to scavenge superoxide radical anion and hydroxyl radical was also evaluated. Superoxide anion is considered to be the "primary" ROS that initiates the generation of other ROS such as hydrogen peroxide and hydroxyl radicals. 27 These toxic oxygen species are involved in the oxidative damage to DNA, proteins and other macromolecules leading to the development of several degenerative diseases associated with aging. 28 Generation of non enzymatic superoxide anion radicals was carried out by mixing phenazine methosulfate (PMS), nicotinamide adenine dinucleotide NADH and air-oxygen. The production of superoxide was estimated by the nitroblue tetrazolium method. 29 As shown in the table 2 compounds with an α,β-unsaturated ketone system (1b, 2e, 4f, 5a, 5b, 5g and 6a-f) presented the best superoxide scavenging activities (higher than that of Caffeic acid used as the reference compound) being the reduced derivatives (6a-f) the most interesting structures with interaction values between 79 and 100 %. This evidence led us to affirm that the olefinic moiety might play an important role in the activity of these compounds by trapping the superoxide radical. The presence of the N-oxide groups in the molecules greatly decreases their scavenging ability.
The competition of compounds with dimethyl sulfoxide (DMSO) for ·OH radicals, generated by the Fe 3+ /ascorbic acid system, expressed as the inhibition of formaldehyde production, was used for the evaluation of their hydroxyl radical scavenging activity. Most of the tested compounds exhibited high competition percentage values at 0.1mM (Table 2 ), similar to that of Trolox used as the reference compound, which indicates that these derivatives are good hydroxyl radical scavengers.
Inhibition of linoleic acid lipid peroxidation.
Lipid peroxidation in cell membrane has been proposed to be a major mechanism for several pathological events including cancer, Parkinson's disease and aging. 30 The ability of the compounds to inhibit lipid peroxidation was measured. 31 Production of conjugated diene hydroperoxide by oxidation of linoleic acid in an aqueous dispersion was monitored at 234 nm. 2,2'-Azobis(2-amidinopropane) dihydrochloride (AAPH) was used as a free radical initiator. The results (Table 2) showed that compounds 6b and 6e were the best inhibitors of lipid peroxidation displaying IC 50 values of 0.01 mM and <0.01 mM respectively. Compounds of series 7 (7a, 7b, 7d and 7e) and 9 (9b and 9d), having a free amino group in their structure, also presented good inhibition activities, especially those with a hydrogen atom (7a and 9a) in position R7 of the quinoxaline ring. Replacement of the hydrogen by a fluoro atom (7b and 9b) resulted in a decrease in the activity, although fluoro derivatives showed also interesting inhibition values of lipid peroxidation.
Inhibition of Soybean lipoxygenase (LOX)
The assay for lipoxygenase (LOX) activity was carried out according to the UV absorbance based enzyme assay 32, 33 using soybean lipoxygenase. While one may not extrapolate the quantitative results of this assay to the inhibition of mammalian 5-LOX, it has been shown that inhibition of plant LOX activity by NSAIDs is qualitatively similar to their inhibition of the rat mast cell LOX and may be used as a simple qualitative screen for such activity.
In general, compounds that displayed good activities as inhibitors of lipid peroxidation also presented good values of inhibition of LOX (table 3) . Thus, the best IC 50 values were shown by compounds of series 7 and 9 (7b>7e>9b>8f>9d>7a). From series 8 only compound 8f presented significant activity. Nevertheless, while the best inhibitors of lipid peroxidation were those compounds without any substitution in the quinoxaline ring, the most interesting activities of LOX inhibition were obtained by fluoro and methyl substituted derivatives.
In vivo anti-inflammatory activity
Two compounds, 7b (which was the most potent LOX inhibitor) and 8f (the most potent from series 8), were tested as in vivo anti-inflammatory agents. In acute toxicity experiments, the in vivo examined compounds 7b and 8f did not present toxic effects in doses up to 0.2 mmol/kg body weight. Ulcerogenicity was not found. Acute inflammation is due to the release of chemical mediators, which cause edema as a result of extravasations of fluid and proteins from the local microvasculature and accumulation of polymorphonuclear leukocytes at the inflammatory site. The in vivo anti-inflammarory effects of the tested quinoxaline derivatives were assessed by using the carrageenin-induced rat paw edema (CPE) model and are presented in Table 3 as percentage of weight increase at the right hind paw. The induced edema is a non-specific inflammation highly sensitive to non-steroidal anti-inflammatory agents (NSAIDs). Thus it has been accepted as a useful tool for studying new anti-inflammatory agents. 34 It reliably predicts the anti-inflammatory potency of the NSAIDs and detects during the second phase that are anti-inflammatory agents as a result of inhibition of prostaglandin amplification. 35 Compound 7b showed 41.3 % percentage of protection while the reference drug indomethacin induced 47 % protection at an equivalent dose. Compound 8f was less potent (28.2 %). No role for lipophilicity was found. Both derivatives presented similar Clog P values (Table  3) .
Experimental Section Chemistry
Microwave assisted synthesis was carried out in a Discover S-Class microwave system apparatus (CEM Corporation). The 1 H NMR spectra were recorded on a Bruker 400 Ultrashield TM (Bruker BioSpin GmbH, Rheinstetten, Germany), using TMS as the internal standard and with CDCl 3 and DMSO-d 6 General method for the microwave assisted synthesis of 1,4-dioxy-quinoxaline-2-carbaldehyde derivatives (compounds IV). In a microwave reaction flask 3 mmol of the appropriate compound III, 4.5 mmol of SeO 2 and 20 mL of acetonitrile were mixed. The reaction was carried out at 200 W for 5 minutes. The solvent was evaporated, an extraction with chloroform and water was performed and the residue purified by column chromatography using toluene:dioxane (3:2). The compounds obtained have been previously described. 20, 36 General method for the microwave assisted synthesis of 1-(substituted-phenyl)-2-(triphenyl-phosphonylidene)-ethanone derivatives (compounds VI). 5 mmol of triphenylphosphine, 5 mmol of the corresponding halide V and 3 mL of xylene were mixed in a microwave reaction flask. The program was run for 1 minute and 30 seconds at 110 W. The residue was dissolved in 10 mL of methanol and 8 mmol of NaH in water were added. The mixture was extracted with ethyl ether (3 x 25 mL), the organic phase dried with anhydrous Na 2 SO 4 and the solvent removed under vacuum to yield compounds VI. Spectroscopic data for compounds VI are listed below. 
1-(3,4,5-trimethoxy-phenyl)-2-(triphenyl-phosphonylidene)-ethanone (VI-a). The compound VI-a was obtained as a white solid (42%

1-(4-methoxy-phenyl)-2-(triphenyl-phosphonylidene)-ethanone (VI-b). The compound VI-b was obtained as a white solid (37%). IR (KBr) 1649 (C=O), 1598-1482 (C-C ar), 1184 (C-O-
Synthesis of 1-(3-Methyl-quinoxalin-2-yl)-ethanone derivatives (Compounds VIII).
These compounds were obtained following the procedure described in the literature. 23 Spectroscopic data for one of these derivatives (VIIIa, R6/R7=H/H) is described below as a reference compound.
1-(3-Methyl-quinoxalin-2-yl)-ethanone (VIIIa).
A 218 mg portion of 2-Acetyl-3-methylquinoxaline 1,4-di-N-oxide (1 mmol) was dissolved in 20 mL of methanol. The solution was heated at 70ºC and 1.04 g of Na 2 S 2 O 4 (6 mmol) in 10 mL of water were added. The mixture was stirred for 10 minutes and the solvent removed under reduced pressure. 
General method for the microwave assisted synthesis of 3-(3-Methyl-1,4-dioxy-quinoxalin-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone derivatives (Series 4) and of 3-(1,4-dioxy-quinoxalin-2-yl)-1-(4-methoxyphenyl)-propenone derivatives (Series 5).
In a microwave reaction flask 0.25 mmol of aldehyde IV, 0.375 mmol of the corresponding ylide VI and 1 mL of methanol were mixed. The reaction was carried out at 25 W for 5 minutes. The solid obtained was filtered and purified by flash column chromatography using toluene:dioxane (3:2) as the eluent. 
(2E)-3-(3-Methyl-1,4-dioxy-quinoxalin-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone (4a). The derivative 4a was obtained as yellow solid (27%). IR (KBr) 1651 (C=O), 1317 (N-O), 1120 (C-O-C)
(2E)-3-(7-Fluoro-3-methyl-1,4-dioxy-quinoxalin-2-yl)-1-(3,4,5-trimethoxy-phenyl)-propenone (4b). The compound 4b was obtained as yellow solid (24%). IR (KBr) 1650 (C=O), 1319 (N-O), 1120 (C-O-C)
(2E)-1-(3-Hydroxy-4,5-dimethoxy-phenyl)-3-(3,6,7-trimethyl-1,4-dioxy-quinoxalin-2-yl)-propenone (4f
(2E)-3-(7-Fluoro-1,4-dioxy-quinoxalin-2-yl)-1-(4-methoxy-phenyl)-propenone (5b
(2E)-3-(7-Chloro-1,4-dioxy-quinoxalin-2-yl)-1-(4-methoxy-phenyl)-propenone (5d
General method for the synthesis of (2E)-1-(3-Methyl-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone derivatives (Series 6).
The synthesis of compounds 6 was carried out as shown in Scheme 2. The starting reagents used (VII and VIII) were obtained by means of previously described methods. 23, 24 To a solution of 1-(3-Methylquinoxalin-2-yl)-ethanone derivative VIII (1 mmol) and 3,4,5-Trimethoxy-benzaldehyde (1 mmol) in methanol, a solution of 3% NaOH in methanol (1 mL) was added. After 24 hours, the reaction mixture was filtered and the solid washed with water. (2E)-1-(3-Methyl-quinoxalin-2-yl)-3-(3,4,5-trimethoxy-phenyl)-propenone (6a) 
General method for the synthesis of 4-(3-Methyl-quinoxalin-2-yl)-6-(3,4,5-trimethoxy-phenyl)-pyrimidin-2-ylamine derivatives (Series 7)
. To a solution of the corresponding compound of series 6 (0.5 mmol) and guanidine hydrochloride (1 mmol) in isopropanol, 0.56 mL of a solution 10% KOH in isopropanol were added. The reaction mixture was refluxing over 24 hours. The solvent was removed under reduced pressure and the crude residue was purified by flash chromatography using hexane:ethyl acetate (50:50) to yield compounds 7. 5-(3-methyl-1,4-dioxy-quinoxalin-2-yl)-3,4-dihydro-2H-pyrazol-3-yl]-phenol (10a) Fluoro-3-methyl-quinoxalin-2-yl)-5-(3,4,5-trimethoxy-phenyl)-4,5-dihydro-pyrazol-1-yl] 
4-(3-Methyl-quinoxalin-2-yl)-6-(3,4,5-trimethoxy-phenyl)-pyrimidin-2-ylamine (7a
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